Standout Papers

The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea a... 2003 2026 2010 2018 576
  1. The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group (2003)
    Paul J. Hesketh, Steven M. Grunberg et al. Journal of Clinical Oncology

Immediate Impact

4 from Science/Nature 60 standout
Sub-graph 1 of 23

Citing Papers

Screening for Osteoporosis to Prevent Fractures
2025 Standout
Neuronal substance P drives metastasis through an extracellular RNA–TLR7 axis
2024 StandoutNature
1 intermediate paper

Works of Judith K. Evans being referenced

Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: A 12-week, randomized, double-blind, placebo-controlled, exploratory study
2009
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
2003 Standout

Author Peers

Author Last Decade Papers Cites
Judith K. Evans 2356 1096 192 421 32 3.0k
Rebecca Clark-Snow 2642 1258 212 336 40 3.4k
Leonidas C. Goudas 910 377 92 822 29 1.7k
Bengt Dahlström 904 474 71 960 40 1.9k
David A. Cherry 748 780 131 972 48 1.8k
Jhi-Joung Wang 674 498 107 207 91 2.0k
Benedikt H. J. Pannen 570 281 363 182 62 2.3k
Allen W. Burton 944 1075 531 2017 74 3.4k
Mark T. Brown 674 457 227 229 55 2.7k
Howard N. Bockbrader 404 1274 87 457 57 3.3k
Neil Singla 1476 299 78 920 74 2.2k

All Works

Loading papers...

Rankless by CCL
2026